Načítá se...
Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy
BACKGROUND: Oesophageal cancer (OC) survival rates have improved since the widespread adoption of neoadjuvant chemoradiation therapy (NACRT) followed by oesophagectomy (trimodality therapy). Unfortunately, the overall prognosis for patients with locally advanced disease remains poor. In this study,...
Uloženo v:
| Vydáno v: | ESMO Open |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069924/ https://ncbi.nlm.nih.gov/pubmed/30094072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000386 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|